What nurse practitioners should know about gene therapy.
1Sarah E. Smith is a Clinical Nurse Educator at Lankenau Medical Center, Wynnewood, PA. Sara J. Reeder is an Associate Professor at Villanova University College of Nursing, Villanova, PA.
The Nurse Practitioner
|October 8, 2013
Summary
Gene therapy is increasingly used in patient care, offering new genomic strategies for chronic disease management. Healthcare professionals, including nurse practitioners, need to be ready to educate patients and collaborate on these advanced treatments.
Area of Science:
- Genomics
- Medical Therapeutics
Background:
- Gene therapy applications in human patients have significantly increased recently.
- Advancements in genomic approaches are emerging for managing chronic diseases.
Purpose of the Study:
- To highlight the growing role of gene therapy in patient care.
- To emphasize the need for nurse practitioner preparedness in gene therapy education and collaboration.
Main Methods:
- Review of recent study findings and clinical applications of gene therapy.
- Analysis of the evolving landscape of genomic medicine.
Main Results:
- Gene therapy represents a rapidly expanding area of clinical practice.
- New genomic strategies are being developed for chronic disease management.
Conclusions:
- Nurse practitioners play a crucial role in supporting patients undergoing gene therapy.
- Collaboration within the medical community is essential for effective gene therapy implementation and patient education.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:49What is Genetic Engineering?
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:14Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...